Tofaris, George K.

α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome

Tofaris, G. K., Layfield, R., & Spillantini, M. G. (2001) · FEBS Letters

Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathways

Cited by 363

Dopamine enhances willingness to exert effort for reward in Parkinson's disease

Chong, T. T.-J., Bonnelle, V., Manohar, S., Veromann, K.-R., Muhammed, K., Tofaris, G. K., Hu, M., & Husain, M. (2015) · Cortex

Parkinson's Disease Mechanisms and TreatmentsNeurotransmitter Receptor Influence on Behavior

Cited by 276

Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal–lysosomal pathway

Tofaris, G. K., Kim, H. T., Hourez, R., Jung, J.-W., Kim, K. P., & Goldberg, A. L. (2011) · Proceedings of the National Academy of Sciences

Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathways

Cited by 271

Facile Impedimetric Analysis of Neuronal Exosome Markers in Parkinson’s Disease Diagnostics

Fu, Y., Jiang, C., Tofaris, G. K., & Davis, J. J. (2020) · Analytical Chemistry

Electrochemical sensors and biosensorsExtracellular vesicles in disease

Cited by 74

Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson’s disease

Yan, S., Zhang, W., Li, X., Dutta, S., Castle, A. R., Liu, Y., Sahoo, A., Lam, C. L., Gatford, N. J. F., Hu, M. T., et al. (2025) · Cell Reports Medicine

Extracellular vesicles in diseaseParkinson's Disease Mechanisms and Treatments

Cited by 33